☆ 4.5 Letter

Ganciclovir for the Treatment of Congenital Cytomegalovirus What are the Side Effects?

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)

Journal

PEDIATRIC INFECTIOUS DISEASE JOURNAL

Volume 33, Issue 1, Pages 115-115

Publisher

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1097/INF.0000000000000032

Keywords

-

Categories

Immunology Infectious Diseases Pediatrics

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Virology

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections

Swetha Pinninti, Suresh Boppana

Summary: Human Cytomegalovirus (HCMV) is a common congenital viral infection, often asymptomatic, but can cause severe infections and long-term sequelae in immunocompromised individuals and in mother-to-child transmission. HCMV prevalence and congenital infection incidence vary based on geographic area and demographics, and there is currently a lack of awareness and effective treatment options for HCMV during pregnancy.

VIRUSES-BASEL (2023)

Add to Collection

Review Infectious Diseases

Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients

Raymund R. Razonable

Summary: This review examines the treatment of cytomegalovirus (CMV) disease in transplant recipients, particularly the use of oral antiviral drugs. Intravenous and oral valganciclovir are the standard first-line treatments. Oral maribavir has shown superior efficacy and safety for refractory or resistant CMV infection.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Add to Collection

Article Medicine, Research & Experimental

Hearing Following Prolonged and Delayed Ganciclovir Treatment in a Murine Cytomegalovirus Model

Katrina Hillam, Daniel Suarez, Christopher Nielson, Abigail Traxler, Elizabeth Sommer, Anna Winslow, Anna Holley, Emily Huang, Maura Hughes, Matthew A. Firpo, Joseph Rower, Albert H. Park

Summary: A delayed course of GCV improved auditory brainstem response (ABR) thresholds in mice infected with cytomegalovirus (CMV), but had no effect on distortion product otoacoustic emission (DPOAE) thresholds. Prolonged GCV administration did not provide better hearing thresholds than standard treatment. Older mice had lower GCV concentrations in their tissue.

LARYNGOSCOPE (2023)

Add to Collection

Review Microbiology

Renal Involvement in Congenital Cytomegalovirus Infection: A Systematic Review

Maria Rios-Barnes, Claudia Fortuny, Ana Alarcon, Antoni Noguera-Julian

Summary: Although typical pathological features of cCMV infection are commonly seen in renal tissue, they do not seem to have significant consequences at the anatomical or clinical levels.

MICROORGANISMS (2021)

Add to Collection

Review Medicine, Research & Experimental

The Effect of (Val)ganciclovir on Hearing in Congenital Cytomegalovirus: A Systematic Review

Elise De Cuyper, Frederic Acke, Annelies Keymeulen, Ingeborg Dhooge

Summary: This systematic review found evidence supporting the treatment of symptomatic children with congenital cytomegalovirus (cCMV) and hearing loss with (val)ganciclovir. However, there is still insufficient evidence for the potential beneficial role of (val)ganciclovir in children with isolated hearing loss, late-onset hearing loss, and asymptomatic cCMV. Future prospective, randomized clinical trials are urgently needed to provide more conclusive evidence.

LARYNGOSCOPE (2022)

Add to Collection

Review Virology

Cytomegalovirus Anterior Uveitis: Clinical Manifestations, Diagnosis, Treatment, and Immunological Mechanisms

Jing Zhang, Koju Kamoi, Yuan Zong, Mingming Yang, Kyoko Ohno-Matsui

Summary: Anterior uveitis (AU) associated with cytomegalovirus (CMV) infection is a common ocular disease, especially in Asia. Prompt diagnosis is crucial to prevent progression to glaucoma. Oral valganciclovir and topical ganciclovir can yield positive outcomes, with higher concentration and frequency benefiting chronic CMV retinitis.

VIRUSES-BASEL (2023)

Add to Collection

Article Infectious Diseases

Long-Term Outcome of Treatment with 2% Topical Ganciclovir Solution in Cytomegalovirus Anterior Uveitis and Corneal Endotheliitis

Po-Jui Chen, I-Huang Lin, Yi-Chun Chi, Chun-Chieh Lai, Jia-Horung Hung, Sung-Huei Tseng, Yi-Hsun Huang

Summary: This study demonstrates that long-term use of topical 2% ganciclovir solution is effective and safe in treating CMV anterior uveitis and corneal endotheliitis in immunocompetent patients. The treatment significantly reduces inflammation, lowers intraocular pressure, and decreases the recurrence rate.

INFECTION AND DRUG RESISTANCE (2022)

Add to Collection

Article Plant Sciences

The bright side of parasitic plants: what are they good for?

Jakub Tesitel, Ai-Rong Li, Katerina Knotkova, Richard McLellan, Pradeepa C. G. Bandaranayake, David M. Watson

Summary: Parasitic plants, often viewed as pests, actually have positive effects on ecosystems and human society, such as facilitating species coexistence, increasing biodiversity, improving nutrient cycling, and providing resources to other organisms. However, caution should be exercised when using parasitic plants, especially avoiding cultivation outside their native geographical range to prevent uncontrolled spread and ecosystem damage.

PLANT PHYSIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

The Multifaceted Clinical Characteristics of Congenital Cytomegalovirus Infection: From Pregnancy to Long-Term Outcomes

Yejin Kim, Yoo-min Kim, Doo Ri Kim, Han Gyeol Kim, Ji-Hee Sung, Suk-Joo Choi, Soo-young Oh, Yae-Jean Kim, Yun Sil Chang, Dongsub Kim, Jung -Sun Kim, Il Joon Moon, Cheong-Rae Roh

Summary: This study aimed to investigate the clinical characteristics of congenital CMV infection from diagnosis to treatment using a multidisciplinary approach. The results showed that prenatal findings have limited ability to detect congenital CMV in Korea. Developmental delay and hearing loss were common long-term outcomes, emphasizing the need for early antiviral treatment and specific diagnostic strategies to reduce the risks of neurologic impairment.

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

Add to Collection

Article Infectious Diseases

Ganciclovir and Valganciclovir Use Among Infants With Congenital Cytomegalovirus: Data From a Multicenter Electronic Health Record Dataset in the United States

Jessica Leung, Scott D. Grosse, Bryan Yockey, Tatiana M. Lanzieri

Summary: The study investigated the use of antiviral treatment in 342 US infants with congenital cytomegalovirus. Among them, 33% received ganciclovir (with or without valganciclovir) and 67% received valganciclovir only. The duration of treatment and the timing of initiation differed for the two drugs, with neutropenia being a common side effect.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2022)

Add to Collection

Article Medicine, General & Internal

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients A Randomized Clinical Trial

Ajit P. Limaye, Klemens Budde, Atul Humar, Flavio Vincenti, Dirk R. J. Kuypers, Robert P. Carroll, Nicole Stauffer, Yoshihiko Murata, Julie M. Strizki, Valerie L. Teal, Christopher L. Gilbert, Barbara A. Haber

Summary: This study compared the efficacy and safety of letermovir with valganciclovir in preventing cytomegalovirus (CMV) disease in kidney transplant recipients. Results showed that letermovir was as effective as valganciclovir in preventing CMV disease over 52 weeks, with lower rates of leukopenia or neutropenia, supporting its use for this indication.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Add to Collection

Review Biochemistry & Molecular Biology

A Review of Murine Cytomegalovirus as a Model for Human Cytomegalovirus Disease-Do Mice Lie?

Michelle A. Fisher, Megan L. Lloyd

Summary: MCMV is used to model HCMV diseases, with laboratory mouse genetic backgrounds affecting disease severity. The advent of genetically modified mice and viruses has allowed new disease aspects to be modeled.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Editorial Material Infectious Diseases

Commentary: Development of Therapeutics for Congenital Cytomegalovirus Infection

Richard J. Whitley

Summary: This article describes the author's experience and progress in studying the therapeutic effects of ganciclovir on congenital cytomegalovirus infection in the mid-1980s. The author expresses gratitude to Syntex for providing the necessary medication and highlights that ganciclovir has become the standard of care for treating this infection.

ANTIVIRAL THERAPY (2022)

Add to Collection

Article Ophthalmology

Cytomegalovirus as a cause of recurrent corneal endotheliitis in the Canadian population

Jamie Bhamra, William Trask, Lisa Lagrou, Bryce Ford, Amin Kherani, Jonathan Wong, Ahmed Al-Ghoul, Andrew Crichton

Summary: This retrospective case series examined the clinical manifestations, response to antiviral treatment, and long-term visual outcomes of cytomegalovirus endotheliitis in a Canadian population. The results showed that treatment with valganciclovir resulted in significant improvements in visual acuity and intraocular pressure, suggesting the efficacy of chronic low-dose antiviral maintenance therapy.

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2023)

Add to Collection

Review Ophthalmology

Clinical characteristics and treatment outcomes of cytomegalovirus anterior uveitis and endotheliitis: A systematic review and meta-analysis

Rina La Distia Nora, Ikhwanuliman Putera, Yuri Dwi Mayasari, Wandya Hikmahwati, Adinda Mulya Pertiwi, Asri Salima Ridwan, Ratna Sitompul, Mark Westcott, Soon-Phaik Chee, Carlos Pavesio, Zheng Xian Thng, Vishali Gupta, Rupesh Agrawal

Summary: This study systematically reviewed the clinical characteristics and treatment outcomes of CMV anterior uveitis and endotheliitis. Acute CMV anterior uveitis commonly presented with high intraocular pressure and mild anterior chamber inflammation, and showed good response to topical ganciclovir gel or oral valganciclovir. Chronic CMV anterior uveitis and endotheliitis required escalated concentration and frequency of treatment, with adequate induction and maintenance phases to prevent recurrences.

SURVEY OF OPHTHALMOLOGY (2022)

Add to Collection

Review Virology

Does bacillusCalmette-Guerinvaccine prevent herpes simplex virus recurrences? A systematic review

Laure F. Pittet, Nigel Curtis

Summary: The BCG vaccine shows potential benefits in reducing HSV infections and recurrences, with animal studies showing significant improvement in survival rates. While non-randomized human studies lack conclusive evidence, there is overall clinical benefit observed, particularly in patients with recurrent herpes labialis. Properly controlled randomized trials are needed to further evaluate the effectiveness of BCG vaccine in preventing HSV infections and recurrences.

REVIEWS IN MEDICAL VIROLOGY (2021)

Add to Collection

Review Pediatrics

Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections

Petra Zimmermann, Nigel Curtis

Summary: The severity of COVID-19 differs between children and adults, with factors that put adults at higher risk and factors that protect children being the main reasons for this difference.

ARCHIVES OF DISEASE IN CHILDHOOD (2021)

Add to Collection

Article Immunology

Candidemia in Children A 16-year Longitudinal Epidemiologic Study

Eloise J. Silvester, Melissa M. Y. Watanabe, Laure F. Pittet, Alison Boast, Penelope A. Bryant, Gabrielle M. Haeusler, Andrew J. Daley, Nigel Curtis, Amanda Gwee

Summary: This study found that the main risk factors for candidemia in children include the presence of a central venous catheter, prior antibiotic exposure, and parenteral nutrition. During the study period, there was an increase in candidemia caused by non-albicans Candida species. The overall mortality rate was low, with significant risk factors for mortality being male sex, liver disease, and mucositis.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)

Add to Collection

Letter Allergy

Refractory thoracic conidiobolomycosis treated with mepolizumab immuno therapy

Daniel K. Yeoh, Thomas Saunders, Coen Butters, David Burgner, Penelope A. Bryant, Timothy M. Cain, Jessica Ng, Amanda Gwee, Andrew J. Daley, Theresa Cole, Nigel Curtis, Joanne Harrison, Joshua Osowicki

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Add to Collection

Review Pediatrics

Should children be vaccinated against COVID-19?

Petra Zimmermann, Laure F. Pittet, Adam Finn, Andrew J. Pollard, Nigel Curtis

Summary: The debate over whether all children under 12 should be vaccinated against COVID-19 continues, with considerations including the relatively low risk of acute COVID-19 in children and the complexity of weighing the risks and benefits of vaccination. Other factors to consider include protection from long-term consequences, population-level impacts, vaccine supply, cost, and avoiding quarantine measures. Ongoing evaluation is needed due to the emergence of new variants of concern.

ARCHIVES OF DISEASE IN CHILDHOOD (2022)

Add to Collection

Article Immunology

Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis

Bahaa Abu-Raya, Kirsten Maertens, Flor M. Munoz, Petra Zimmermann, Nigel Curtis, Scott A. Halperin, Nynke Rots, Daan Barug, Beth Holder, Thomas F. Rice, Beate Kampmann, Elke Leuridan, Manish Sadarangani

Summary: This study found that infants born to women immunized with Tdap had lower IgG levels against pertussis toxin and diphtheria toxoid post-primary immunization. The timing of Tdap immunization in pregnancy and spacing of infant immunization did not affect the antibody levels. In contrast, higher IgG levels of vaccine antigens pre-primary immunization in infants of unimmunized women were associated with lower post-primary and post-booster immunization levels, but the clinical significance is uncertain.

VACCINE (2021)

Add to Collection

Article Immunology

Revaccination with Bacille Calmette-Guerin (BCG) is associated with an increased risk of abscess and lymphadenopathy

Paola Villanueva, Ushma Wadia, Nigel Crawford, Nicole L. Messina, Tobias R. Kollmann, Michaela Lucas, Laurens Manning, Peter Richmond, Laure F. Pittet, Nigel Curtis

Summary: The frequency and types of adverse events following initial vaccination and revaccination with Bacille Calmette-Guerin (BCG) vary worldwide. A randomised controlled trial (the BRACE trial) using active surveillance determined the incidence and risk factors for BCG injection site abscess and regional lymphadenopathy. Revaccination with BCG increases the risk of injection site abscess and lymphadenopathy.

NPJ VACCINES (2022)

Add to Collection

Review Pediatrics

What is the significance of an accelerated BCG reaction in children?

Paola Villanueva, Laure F. Pittet, Clare Nourse, Nigel Curtis

ARCHIVES OF DISEASE IN CHILDHOOD (2022)

Add to Collection

Article Immunology

Non-tuberculous Mycobacterial Infection of the Retropharyngeal Space

Alastair Weng, Nigel Curtis, Seilesh Kadambari, Kaya Gardiner, David Burgner, Amanda Gwee

Summary: This case report discusses a 20-month-old girl with Mycobacterium avium complex infection of the retropharyngeal space, and summarizes the literature on the pathogenesis and management of nontuberculous mycobacterial infections in the retropharynx.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Add to Collection

Article Immunology

An Approach to the Treatment of Children With COVID-19

Alison Boast, Nigel Curtis, Johanna Holschier, Rachael Purcell, Samantha Bannister, Christine Plover, Maidhili Chinnapan, David Burgner, Suzanne L. Boyce, Sarah McNab, Amanda Gwee

Summary: There is limited data to guide treatment recommendations for children with acute, symptomatic COVID-19. This review proposes a management approach based on published evidence, approved medications, and safety profiles of recommended drugs in this age group.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Add to Collection

Letter Allergy

Bacillus Calmette-Guerin vaccination to prevent childhood asthma: A revised meta-analysis

Laure F. Pittet, Nigel Curtis

ALLERGY (2022)

Add to Collection

Review Immunology

Monkeypox-What Pediatricians Need to Know

Petra Zimmermann, Nigel Curtis

Summary: Monkeypox is a zoonotic disease that has recently seen a global increase in cases, predominantly among men who have sex with men. While previous outbreaks have disproportionately affected children, the risk to children from the clade II strain is unclear. Nonetheless, children and pregnant women are considered high-risk groups and should be considered for antiviral treatment. Smallpox vaccination offers protection, but the duration of this protection is unknown, and vaccinated individuals can still be infected. Authorities should be prepared to vaccinate children if the current outbreak spreads.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Add to Collection

Article Immunology

To ChatGPT or not to ChatGPT? The Impact of Artificial Intelligence on Academic Publishing

Nigel Curtis, ChatGPT

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2023)

Add to Collection

Review Immunology

Interpreting the Results of Trials of BCG Vaccination for Protection Against COVID-19

Christie C. A. Noble, Nicole L. Messina, Laure F. Pittet, Nigel Curtis

Summary: BCG vaccination has potential off-target effects on nonmycobacterial infections. Trials investigating the off-target protection of BCG against COVID-19 have shown conflicting results, likely due to differences in participant characteristics, BCG vaccination variables, outcome measures, and follow-up durations. Controlling these factors will be crucial in designing future trials and intervention strategies to fully exploit the off-target effects of BCG.

JOURNAL OF INFECTIOUS DISEASES (2023)

Add to Collection

Article Immunology

Off-target effects of bacillus Calmette-Guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19

Nicole L. Messina, Susie Germano, Rebecca McElroy, Rajeev Rudraraju, Rhian Bonnici, Laure F. Pittet, Melanie R. Neeland, Suellen Nicholson, Kanta Subbarao, Nigel Curtis

Summary: BCG vaccination has immunomodulatory effects on SARS-CoV-2 and reduces the secretion of cytokines associated with severe COVID-19. In addition, BCG vaccination promotes specific T cell immune responses and activates eosinophils.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.